SCHEMBL5805405

SCHEMBL5805405

O=C(CN1CCCCC1C1=COC=C(C2=CC=CCC2)O1)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.42
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 7/20 0.41
ALDH1A1 P00352 6/20 0.40
GAA P10253 2/20 0.40
HTT P42858 4/20 0.39
MAPK1 P28482 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
USP2 O75604 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
POLB P06746 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5808924 0.71 LMNA (0.47) MAPTTP53SMN1; SMN2NPSR1LMNA
SCHEMBL5805401 0.71 NCOA1 (0.51) MAPTTP53SMN1; SMN2NPSR1LMNA
SCHEMBL5796637 0.69 LMNA (0.59) MAPTTP53SMN1; SMN2NPSR1LMNA
SCHEMBL5794482 0.69 MAPT (0.56) MAPTTP53SMN1; SMN2NPSR1LMNA
SCHEMBL21498009 0.67 MAPT (0.72) MAPTTP53SMN1; SMN2NPSR1LMNA
SCHEMBL2420495 0.66 ALDH1A1 (0.34) SMN1; SMN2NPSR1ALDH1A1HTTPOLB
SCHEMBL4922701 0.64 NPSR1 (0.38) MAPTSMN1; SMN2NPSR1LMNAALDH1A1
SCHEMBL26546756 0.64 KDR (0.76) MAPTTP53SMN1; SMN2NPSR1LMNA
SCHEMBL5820332 0.63 LMNA (0.54) MAPTSMN1; SMN2NPSR1LMNAALDH1A1
SCHEMBL7292316 0.62 MAPT (0.69) MAPTTP53SMN1; SMN2NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006015279-A1 HETEROCYCLIC DIAMINE COMPOUNDS AS LIGANDS OF THE MELANIN CONCENTRATING HORMONE RECEPTOR USEFUL FOR THE TREATMENT OF OBESITY, DIABETES, EATING AND SEXUAL DISORDERS NEUROGEN CORPORATION (US) 2006-02-09 WO claimed